a r t I C l e S Glia are highly sensitive to nervous system insults, including acute injury, infection and neurodegenerative disease. Neuronal injury triggers reactive gliosis, a robust glial response that includes dramatic changes in glial gene expression and cell morphology 1, 2 . Reactive glia rapidly extend membrane processes toward damage sites and clear degenerating neurons through phagocytic engulfment, then return to a resting state in which pre-injury morphology and molecular profile is restored 3, 4 .
Damaged neurons release a battery of toxic factors that threaten the health of neighboring cells. Reactive glia counteract these effects by clearing excess glutamate to prevent excitotoxicity 5 and secreting protective molecules 6 . Glial clearance of degenerating neurons prevents large-scale release of proteases and cytosolic antigens, which can activate inflammatory immune responses 7, 8 . However, some reactive glial responses are highly detrimental and can actively promote the destruction of healthy neurons. For example, chronic exposure to amyloid plaques characteristic of Alzheimer's disease causes microglia to continuously release pro-inflammatory agents 9 . In addition, activation of glial scavenger receptors and phagocytic activity stimulates secretion of harmful reactive oxygen species [10] [11] [12] . Given the powerful effects of reactive glia on neuronal survival, tight regulation of their interactions with neurons after trauma is essential to minimize damage.
In professional immune cells, such as macrophages, many immune responses are regulated by receptors that contain ITAMs, defined by a consensus sequence YXXI/LX [6] [7] [8] [9] [10] [11] [12] YXXI/L, that signal through non-receptor tyrosine kinase cascades 13 . ITAM signaling can be negatively regulated by receptors that bear a related ITIM. ITIMs recruit the Src homology 2 (SH2) domain-containing protein tyrosine phosphatases (SHP) SHP-1 and/or SHP-2, which dephosphorylate ITAM domains, key downstream signaling kinases, or adaptor molecules 14, 15 . Notably, ITAM and ITIM signaling molecules are expressed in mammalian microglia 16, 17 , but the role of ITAM and ITIM during glial responses to trauma remains unclear.
The Drosophila engulfment receptor Draper, which regulates glial clearance of axon debris in the injured adult brain, has recently been shown to signal through an ITAM-Src-Syk-like signaling pathway. Extension of glial membranes to injury sites and glial clearance of axonal debris requires the ITAM-bearing receptor Draper, the Src kinase Src42A and the non-receptor tyrosine kinase Shark 8, 18 . Here we explored how glial responses to axon injury are encoded by Drosophila melanogaster Draper receptor isoforms and found that unique isoforms have strikingly different roles in glial responses to axonal injury: the Draper-I isoform activated engulfment activity, whereas the alternatively spliced Draper-II isoform potently blocked all glial responses to axonal injury. Draper-II associated with the protein tyrosine phosphatase Corkscrew (Csw) through an intracellular ITIM-like domain to negatively regulate glial responses to injury. Notably, upon loss of Draper-II-Csw signaling, glia failed to terminate responses to axonal injury and had a reduced ability to respond to secondary nerve lesions. These data argue that a balance of the opposing actions of Draper-I-ITAM and of Draper-II-ITIM-like signaling fine-tune glial responses to neurodegeneration.
RESULTS

Drosophila adult glia express three Draper isoforms
Three Draper receptor isoforms (Draper-I, Draper-II and Draper-III) are generated through alternative splicing of the draper gene transcript, and each contains a unique combination of extracellular and intracellular sequences (Fig. 1a) 19 . To determine which isoforms are present in the adult brain, we prepared head-protein lysates a r t I C l e S from control yw and draper ∆5 null mutant flies and performed western blotting using an antibody that recognizes all three Draper isoforms 19 . We detected bands corresponding to at least two Draper isoforms ( Fig. 1b and Supplementary Fig. 1 ): a larger, predominant band representing Draper-I (113 kDa) and a smaller band or bands at the predicted sizes of Draper-II and/or Draper-III (65 kDa and 59 kDa, respectively). Because it was difficult to resolve Draper-II and Draper-III, we performed RT-PCR and detected transcripts for all three isoforms in whole adult heads and dissected brains. draper-I and draper-III are also expressed in embryos, larval brains and larval body wall tissue. Notably, draper-II is selectively expressed in adults (Supplementary Fig. 2 ).
Draper-I is required for glial engulfment of severed axons Surgical ablation of the antennae or maxillary palps severs olfactory receptor neuron (ORN) axons that project into the brain, triggering their destruction through Wallerian degeneration. Glia infiltrate the injury site and engulf ORN axonal debris, but in the absence of Draper, glia fail to react and axonal debris lingers in the brain 8, 18 . To determine how each Draper isoform modulates glial responses to injury in vivo, we used the pan-glial driver repo-Gal4 to drive expression of UAS-draper-I, UAS-draper-II, or UAS-draper-III in draper ∆5 null mutants, then severed ORN axons and assayed glial clearance of axon debris (Fig. 1c,d) . We confirmed expression of each UAS-draper transgene by anti-Draper immunostaining (Fig. 1c) and immunoblotting (Fig. 1e) . Next, we quantified clearance of degenerating GFP + axons (OR85e-mCD8øGFP) three days after axotomy. In controls, GFP + axonal debris was cleared from the brain, whereas virtually all GFP + degenerating ORN axons persisted in draper ∆5 mutants (Fig. 1c,d ) 8 . Notably, glial expression of Draper-I rescued the engulfment defect of draper mutants to near-control levels. In contrast, expression of Draper-II or Draper-III failed to rescue draper engulfment defects (Fig. 1c,d ). Glia cleared severed axons normally in heterozygous UASdraper flies (Supplementary Fig. 3 ), indicating that these phenotypes were not a result of insertional transgene effects. Thus, Draper-I, but not Draper-II or Draper-III, is sufficient for glial phagocytic engulfment of degenerating axons in the adult brain.
To determine whether loss of Draper-I was sufficient to suppress engulfment activity, we generated an RNA interference (RNAi) construct (UAS-draper-I RNAi ) that targets the unique extracellular domain region in Draper-I (Fig. 1a) 20 . We first confirmed specificity by ubiquitously driving UAS-draper-I RNAi and performing antiDraper immunoblotting (Fig. 2a) . Next, we used repo-Gal4 to drive UAS-draper-I RNAi and assessed glial clearance of severed axons. Clearance of degenerating axons was substantially inhibited, to levels indistinguishable from those observed by knockdown of all Draper isoforms or in draper null mutants Fig. 2b,c) . We also noted that glial expression of UAS-draper-I RNAi resulted in the loss of the majority of Draper staining (Fig. 2b) , suggesting that Draper-I is the predominant isoform in adult glia. These clearance phenotypes were not an artifact of activating the RNAi machinery, as repo-Gal4-driven RNAi targeting other genes did not affect clearance of severed axons (Supplementary Fig. 4 ). Because glial expression of Draper-II and Draper-III is retained in Draper-I RNAi flies, we conclude that these isoforms are not sufficient to drive glial engulfment of degenerating axons. Together, our findings suggest that Draper-I is necessary and sufficient for glial engulfment of axonal debris after axotomy.
The Draper-I intracellular domain activates engulfment Because Draper-I is structurally unique in both its extracellular and intracellular domain compared to Draper-II and Draper-III, engulfment-promoting activity could map to either region. To examine this, we generated chimeric receptors that contained every combination of extracellular (ex) and intracellular (int) domains from each Draper isoform (Fig. 3a) and tested the ability of each to promote glial engulfment of severed axons. We first confirmed that each construct was stably expressed in adult brains (Fig. 3b) . Next, we examined (Fig. 3c,d) . Thus, the shorter extracellular domains of Draper-II or Draper-III can functionally replace that of Draper-I during glial clearance of severed axons. We next asked whether the intracellular domain of Draper-I contains unique engulfment-promoting activity. All three isoforms contain an NPXY motif proposed to bind the phosphotyrosine-binding adaptor molecule Ced-6 (refs. 21-25), but, because only Draper-I rescued the draper engulfment defect, this domain is not sufficient for clearance of degenerating axons. Draper-I also contains an essential intracellular ITAM (Fig. 3e) 18 , and a C-terminal truncation in Draper-III deletes half of this ITAM sequence, including a key tyrosine residue. Overexpression of Draper-I ex -III int in draper-mutant glia did not rescue the engulfment defect (Fig. 3c,d) , supporting the notion that a complete ITAM domain is required for Draper-I-mediated engulfment of severed axons.
The intracellular domain of Draper-II contains an 11-aminoacid insertion in the middle of the ITAM present in Draper-I (Fig. 3e) . When we expressed Draper-I ex -II int in draper-mutant glia, we found that this chimeric isoform failed to rescue clearance of axonal debris (Fig. 3c,d) . Thus, although the extracellular domains of Draper are fully interchangeable, only the Draper-I intracellular domain is sufficient to drive glial engulfment activity. Notably, the 11-amino-acid insertion in the intracellular domain of Draper-II renders this isoform incapable of promoting glial engulfment activity.
Draper-II inhibits engulfment through an ITIM-like domain
Upon closer inspection of Draper-II, we identified a motif with a sequence reminiscent of an ITIM (VKIYXXI, Fig. 3e ). Mammalian receptors bearing ITIMs inhibit ITAM signaling cascades 14, 15, 26 , which raised the intriguing possibility that Draper-II negatively regulates Draper-I. To test this idea, we first overexpressed Draper-II in glia of wild-type flies and found that glial clearance of axonal debris was completely blocked (Fig. 4a,b) . Likewise, glial overexpression of Draper-I ex -II int blocked glial engulfment of GFP + debris (Fig. 4a,b) . In contrast, we overexpressed Draper-I or Draper-III in wild-type glia and discovered that engulfment activity was comparable to that of control flies (Fig. 4a,b) . Thus, the inhibitory activity of Draper-II maps to the intracellular domain, and because the unique feature of this domain is the ITIM-like motif, we conclude that this motif confers inhibitory signaling activity.
Finally, because Gal4-UAS-driven Draper-II levels were much higher than endogenous Draper levels, we reasoned that high concentrations of Draper-I might overcome the inhibitory activity of Draper-II. We expressed Draper-I and Draper-II together in glia using repo-Gal4 but found that glial engulfment of axonal debris was still potently suppressed (Fig. 4a,b) . Thus, providing roughly equivalent concentrations of Draper-I and Draper-II is insufficient to overcome the inhibitory activity of Draper-II, which may explain the predominance of Draper-I in wild-type brains.
Corkscrew preferentially binds Draper-II In vertebrates, the tyrosine phosphatases SHP-1 and SHP-2 typically bind ITIMs 14, 27 . We explored the possibility that Draper-II might associate with Csw, the Drosophila homolog of SHP-1 and SHP-2. We transfected Drosophila S2 cells with plasmids for wild-type Csw (Csw WT ) and hemagglutinin (HA)-tagged versions of Draper-I or Draper-II, then immunoprecipitated with anti-Csw antibody and performed anti-HA and anti-Csw western blotting of these samples. We consistently detected robust association of Csw with Draper-II, and, notably, significantly more HA-tagged Draper-II co-immunoprecipitated with Csw compared to Draper-I (Fig. 5a , lane 4 versus lane 5, 24 ± 1.7-fold increase, P < 0.0001), indicating that Csw preferentially associates with Draper-II.
Catalytically inactive phosphatases can bind target substrates, but, because they cannot dephosphorylate the phosphotyrosine residues required for dissociation, they fail to release, thereby 'trapping' the substrates [28] [29] [30] . As an alternative strategy to show Draper-II-Csw npg a r t I C l e S association, we used a substrate-trapping Csw, Csw C583S (Csw CS ) 30 . We transfected plasmids encoding Csw CS , Csw WT and/or Draper-IIøHA, immunoprecipitated with anti-Csw, and performed western blotting with anti-HA to visualize Draper-IIøHA. We found that more Draper-IIøHA co-immunoprecipitated with the catalytically inactive Csw CS as compared to Csw WT (Fig. 5b , lane 4 versus lane 5, 1.7 ± 0.15-fold increase, P < 0.05), suggesting that Draper-II is a Csw substrate requiring Csw catalytic activity for dissociation. These results, together with the presence of an ITIM-like sequence in Draper-II and the ability of Draper-II to inhibit ITAM-mediated signaling during glial engulfment in vivo, strongly implicate Draper-II as a functional ITIM-like receptor that negatively regulates glial engulfment activity.
Draper-II is dephosphorylated by Corkscrew
To determine whether Csw alters the tyrosine phosphorylation status of Draper, we transfected S2 cells with plasmids encoding Csw WT , Csw CS and HA-tagged Draper-I or Draper-II and performed anti-HA immunoprecipitation followed by anti-phosphotyrosine immunoblotting. Coexpression of Csw WT caused a striking reduction in the intensity of the anti-phosphotyrosine band for Draper-IIøHA (Fig. 5c , lane 7 versus lane 8, 28 ± 4% decrease, P < 0.01). In contrast, Draper-II phosphorylation was significantly higher when Csw CS was coexpressed (Fig. 5d , lane 6 versus lane 7, 330 ± 90% increase, P < 0.01), arguing that Draper-II is a phosphatase substrate for Csw. Tyrosine phosphorylation of Draper-I was unaffected by Csw, as we found no significant changes in the phosphorylation status of Draper-IøHA when coexpressed with Csw WT (Fig. 5c , lane 5 versus lane 6, 6 ± 3% decrease, P = 0.13) or Csw CS (Fig. 5d , lane 4 versus lane 5, 40 ± 60% increase with Csw CS , P = 0.85). We note that it remains possible that Draper-I is a Csw substrate in vivo, given that expression of constructs in cultured cells does not fully mimic an engulfment event. Nevertheless, these results suggest that Draper-II is a physiological substrate for Csw, whereby Csw dephosphorylates the intracellular domain of Draper-II, perhaps to facilitate the dissociation of Csw or other signaling molecules. We wondered whether Draper-IIøHA and Csw signaling might affect the tyrosine phosphorylation status of Shark, which is required for Draper-mediated engulfment in vivo 18 . We therefore expressed Draper-IøHA or Draper-IIøHA and N-terminal Myc-tagged Shark (MycøShark) with or without Csw WT in S2 cells and performed anti-HA immunoprecipitation. We found that Csw WT significantly reduced the intensity of the Shark anti-phosphotyrosine band in the presence of Draper-IIøHA (Fig. 5c , lane 7 versus lane 8, 32 ± 2.6% decrease, P < 0.01), but not in the presence of Draper-IøHA (Fig. 5c , lane 5 versus lane 6, 7 ± 12% decrease with Csw WT , P = 0.59). Anti-phosphotyrosine Shark levels were higher in the presence of Csw CS compared to Csw WT when these were coexpressed with Draper-IIøHA (Fig. 5d , lane 6 versus lane 7, 520 ± 140%-fold greater for Shark, P < 0.05). Notably, tyrosine phosphorylation of Shark was not significantly altered by Csw CS in the presence of Draper-IøHA (Fig. 5d , lane 5 versus lane 4, 9 ± 40% increase, P = 0.82). We also performed reciprocal experiments in which we coexpressed Draper-IIøHA and MycøShark with Csw WT or Csw CS (or no Csw), immunoprecipitated Shark using anti-Myc and analyzed the tyrosine-phosphorylation status of Shark. Again, we found that phosphorylation of MycøShark was consistently reduced when it was coexpressed with Csw WT (Fig. 5e , lane 2 versus lane 3, 10% ± 3% decrease, P < 0.05), but increased in the presence of Csw CS (Fig. 5e, lane 2 versus 4 , 21% ± 8% increase, P < 0.05). Finally, we (Fig. 5d, lanes 4-7) . Together, these data support a model whereby Draper-II and Csw inhibit glial engulfment activity by reducing the activity of Draper-I signaling effectors, including Shark, through targeted dephosphorylation.
Corkscrew is required for Draper-II inhibitory activity
To determine whether Csw was required for Draper-II signaling in vivo, we assayed the effects of csw mutants and RNAi on Draper-II-dependent inhibition of glial engulfment. Glial overexpression of Draper-II completely blocked engulfment of severed axons, but this phenotype was significantly suppressed in heterozygous mutant csw va199 flies 31, 32 (Fig. 6a,b , P < 0.0001). Glial engulfment activity was normal in csw va199/+ flies, indicating that Csw is not a positive regulator of glial engulfment. To determine the cell autonomy of Csw function, we used repo-Gal4 to drive UAS-csw RNAi expression in glia (Supplementary Fig. 5 ) and found that this significantly suppressed the inhibitory activity of Draper-II (Fig. 6c,d , P < 0.0001). Thus, Csw, like Draper-II, functions in glia to inhibit engulfment activity. 
Draper-II-Csw terminates glial responses to axon injury
Our findings suggest that Draper-I and Draper-II each have important, but opposing, roles in glial responses to axotomy. Previous work has shown that Draper immunoreactivity is robustly upregulated in antennal lobe glia within 24 h after ORN axon injury 8 . We performed real-time quantitative PCR (qRT-PCR) on central brains at 0, 1.5, 3, 4.5, 6, 12 and 24 h and 7 d after axon injury. We found that draper-I mRNA abundance was increased within 1.5 h after axotomy (Fig. 7a , P < 0.05). Notably, draper-II transcripts also increased (P < 0.05), although these levels did not peak until 4.5 h after ablation (Fig. 7a) . csw levels also appear to be modulated by injury and were significantly decreased (P < 0.05) at 4.5 h, in coordination with Draper-II increases (Supplementary Fig. 6 ). Thus, draper-I and draper-II transcript levels are regulated in response to injury, with upregulation of the pro-engulfment isoform preceding that of the inhibitory Draper-II isoform.
As Draper-II-Csw negatively regulates glial engulfment activity, we suspected that Draper-II-Csw signaling might function to downregulate glial responses to injury after axon clearance. We therefore assayed the efficiency of initiation and termination of glial responses to antennal nerve axotomy in wild-type and Csw RNAi flies. We first asked whether the expression of key glial engulfment molecules (that is, Draper and Ced-6) was regulated normally before and after injury. Glial knockdown of Csw had no effect on the basal expression of Ced-6 or Draper protein in uninjured flies (Fig. 7b-e) . Both control and Csw RNAi flies exhibited a robust increase in Ced-6 and Draper protein in antennal lobe glia 1 and 5 d after ORN axotomy (Fig. 7b-e) , indicating that glial engulfment responses were activated normally. Furthermore, we observed no difference in clearance of degenerating axons 5 d after maxillary nerve injury in control versus Csw RNAi flies ('single injury' , Fig. 8a,b) , indicating that glial engulfment of severed axons occurred normally in Csw RNAi backgrounds. In controls, at 7 and 10 d after injury, Draper levels returned to baseline, whereas Ced-6 remained elevated, indicating that glia were terminating responses. However, in Csw RNAi flies, Ced-6 levels were further elevated at 10 d, and Draper levels remained high at 7 and 10 d (Fig. 7b-e) . These data argue that loss of Draper-II-Csw signaling results in a prolonged glial response and subsequent failure to properly terminate glial responses to axotomy.
Sustained expression of engulfment molecules after a primary injury might enhance glial responses to subsequent injuries. Alternatively, a failure to terminate glial responses to axotomy might negatively affect the responsiveness of glial cells to further injury events. To discriminate between these possibilities, we developed a serial axotomy assay (Supplementary Fig. 7) . Briefly, in flies expressing GFP in maxillary palp neurons, we generated a primary antennal nerve lesion to activate glial injury responses. Five days later, we performed a second (maxillary nerve) axotomy, and then assayed clearance of OR85e + axonal debris. Interestingly, whereas control flies had cleared most axonal debris by 5 d after the secondary injury, Csw RNAi flies failed to efficiently clear GFP + axonal debris at this time point (Fig. 8a-c) , and we observed nearly twice as many brains that contained visible axonal tracts of fragmented GFP + material ( Fig. 8c ; 42% in controls versus 83% in Csw RNAi flies). Uninjured maxillary palp ORNs appeared morphologically normal after the initial injury in control and Csw RNAi flies (Fig. 8d,e) , arguing that activated wild-type and Csw RNAi glia do not promote the indiscriminant destruction of uninjured axons in the area of injury. Together, these data argue strongly that Draper-II and Csw form a functional ITIM-like signaling cascade that suppresses Draper-I-ITAM signaling and is essential for the proper termination of glial responses to axonal injury in vivo. Furthermore, this work reveals a previously undescribed role for Draper and ITIM-like signaling in maintaining glial responsiveness to neural trauma, because efficient termination of an initial glial response seems to be crucial for glia to respond subsequent neural injury.
DISCUSSION
Here we show how a single receptor, Draper, can positively or negatively influence glial responses to axonal injury. Our work reveals a crucial role for ITAM and ITIM-like signaling events in regulating the activation, termination and maintenance of engulfment signal transduction cascades during glial responses to axonal injury. In addition, we provide direct evidence that negative regulation of glial responses a r t I C l e S to neurodegeneration is essential for glia to reset their responses after an initial injury, and thereby remain competent to respond efficiently to subsequent brain trauma.
The Draper intracellular domain directs engulfment
The unique intracellular domains of Draper-I and Draper-II determine their effects on glial responses to axonal injury. Whereas Draper-I promoted engulfment of axonal debris, Draper-II completely inhibited glial clearance of degenerating axons, and the inhibitory activity mapped to a Draper-II-specific intracellular motif that contains an ITIM-like domain. We note that this insertion also produces two ITAMs in Draper-II, raising the possibility that one or both of these may function as an inhibitory ITAM (ITAMi). Recent work has shown that some ITAMs function in a dual manner, recruiting activating or inhibitory effectors in response to changes in receptor configuration 33 . However, we favor a model in which Draper-II acts exclusively as an inhibitory ITIM-like receptor, as the ITIM-like Draper-II domain is not a functional activator in any context we have examined in vivo.
There are two unique Draper extracellular domains that are likely to be involved in recognition of engulfment targets (Fig. 1a) . These are fully interchangeable in our engulfment assay, indicating that neither extracellular domain contains inherent inhibitory activity. It is possible that both domains recognize the same molecule, perhaps a ligand presented by degenerating axons. Alternatively, each extracellular domain may recognize a unique ligand. Identifying specific factors that associate with the extracellular region of each Draper isoform after axotomy will provide key insight into these post-injury neuron-glia communication events.
Draper-II-Corkscrew signaling reprimes glia after injury Following axotomy, engulfment molecules (Draper and Ced-6) are robustly upregulated in responding glia 8, 23 and return to baseline levels once axonal debris has been cleared (Fig. 7) . Notably, we found that Csw signaling is essential to restore Draper and Ced-6 to basal levels as glia terminate responses to axotomy and that glia lacking Draper-II-Csw signaling fail to respond to secondary injuries in the brain. These data highlight previously unknown in vivo requirements for Draper-I and Draper-II-Csw signaling in coordinating the activation, termination and maintenance of glial cellular responses to axonal injury.
We propose that Draper-I, acting via Src42A and Shark, promotes the expression of engulfment genes after axotomy and phagocytosis of degenerating axons; such upregulation of engulfment genes is probably essential for rapid clearance of degenerating axons. We also propose that Draper-II and Csw then negatively regulate Draper-I signaling to terminate reactive glial responses and allow glia to return to a resting state. Our data showing differential regulation of Draper-I and Draper-II transcripts, with Draper-I preceding Draper-II by several hours, supports the idea that Draper-II-Csw signaling may be delayed relative to Draper-I-ITAM signaling, thereby allowing for potent activation and temporal regulation of responses. Curiously, csw transcript levels seem to decrease ~4 h after injury, suggesting that although Draper-II and Csw are both influenced by post-injury signaling, they are differentially regulated.
It will be important in the future to identify additional factors functioning within the Draper-II-Csw inhibitory signaling pathway. Following engagement of mammalian ITIM receptors, activated SHP-1 or SHP-2 can target the Src-family kinases that phosphorylate the crucial ITAM tyrosine residues required for ITAM receptor signaling 34 . Thus, Src42A, the kinase that phosphorylates the Draper-I ITAM, may also be an in vivo Csw target. SHP phosphatases can also influence gene transcription within immune cells, although it is largely unclear how this occurs at the molecular level 35 .
Our discovery that unique Draper isoforms execute opposing functions during the engulfment of degenerating axons raises interesting questions regarding the putative function of Draper homologs in other species. The related mammalian receptors Jedi-1 and MEGF10 are expressed in glia and play a conserved role in glial phagocytic activity [36] [37] [38] . Jedi and MEGF10 drive engulfment in peripheral glia that clear large numbers of apoptotic neurons in the developing dorsal root ganglia 38 . It is unknown whether splice variants of Jedi or MEGF10 exist. Notably, the role of Draper-II may be specific to adults; we did not detect Draper-II transcript at embryonic or larval stages, which may indicate that the exuberant phagocytic activity of glia that occurs during nervous system development does not require negative regulation.
We predict that inhibitory constraints on reactive gliosis will be common to many organisms, and that these constraints will be particularly important in the context of neuropathological conditions. It is well known that reactive microglia can actively destroy neurons through phagocytic activity [10] [11] [12] 39 and reactive glia release a number of factors to promote neuronal death or inhibit neuronal function 11, 40, 41 . Maintaining glial cells in an activated state might exacerbate these effects. The roles of MEGF10 and/or Jedi in glial response to adult neural injury have not yet been examined, but there is evidence that ITIM-mediated pathways may provide neuroprotection. For example, in the SHP-1 knockout mouse motheaten there is striking evidence of enhanced microglial activation and neurodegeneration after acute neuronal damage 42 .
Promoting glial termination of reactive responses may be particularly important in neurodegenerative disease, which amounts to a continuous series of neural injuries. Reactive gliosis is certainly a hallmark of nearly all neurodegenerative diseases 9, 16 and there is growing evidence that glia help to promote disease pathology in mouse models [43] [44] [45] [46] . The Draper-II-Csw signaling pathway is remarkably specific in its negative regulation of glial responses to axonal injury, and it provides an exciting molecular entry point to understanding how glial cells terminate cellular and molecular responses to neural trauma.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
